Interact to see
Advertisement
Advertisement
BAPR vs FMAR
BAPR vs FMAR Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
BAPR vs. FMAR commentary
Jul 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAPR is a Hold and FMAR is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
FMAR has more net assets: 899M vs. BAPR (411M). FMAR has a higher annual dividend yield than BAPR: FMAR (3.945) vs BAPR (2.595). BAPR was incepted earlier than FMAR: BAPR (6 years) vs FMAR (4 years). BAPR (0.79) has a lower expense ratio than FMAR (0.85).
| BAPR | FMAR | BAPR / FMAR | |
| Gain YTD | 2.595 | 3.945 | 66% |
| Net Assets | 411M | 899M | 46% |
| Total Expense Ratio | 0.79 | 0.85 | 93% |
| Turnover | N/A | 0.00 | - |
| Yield | 0.00 | 0.00 | - |
| Fund Existence | 6 years | 4 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| BAPR | FMAR | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 59% | 4 days ago 51% |
| Stochastic ODDS (%) | 4 days ago 45% | 4 days ago 50% |
| Momentum ODDS (%) | N/A | 7 days ago 73% |
| MACD ODDS (%) | 4 days ago 76% | 4 days ago 76% |
| TrendWeek ODDS (%) | 4 days ago 75% | 4 days ago 72% |
| TrendMonth ODDS (%) | 4 days ago 71% | 4 days ago 68% |
| Advances ODDS (%) | 4 days ago 72% | 4 days ago 69% |
| Declines ODDS (%) | N/A | N/A |
| BollingerBands ODDS (%) | 4 days ago 57% | 4 days ago 52% |
| Aroon ODDS (%) | 4 days ago 70% | 4 days ago 64% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYVFX | 9.96 | 0.08 | +0.81% |
| Royce Small-Cap Value Service | |||
| HCPCX | 54.31 | 0.40 | +0.74% |
| Hartford Capital Appreciation HLS IC | |||
| FNFWX | 89.57 | 0.55 | +0.62% |
| American Funds New World 529-F-2 | |||
| FQTEX | 13.36 | 0.04 | +0.30% |
| Franklin Templeton SMACS: Series E Adv | |||
| CSHZX | 12.28 | N/A | N/A |
| NYLI Cushing® MLP Premier Class I | |||